|
Video: What is a Stock Split?
|
|
China Pharma Holdings is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with a variety of diseases and medical conditions. Co. manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Co. manufactures pharmaceutical products for a variety of diseases and medical indications, each of which may be classified into the following categories: basic generic drugs; first-to-market generic drugs; and Chinese medicines. In addition, Co. manufactured healthcare products and protective products. According to our China Pharma Holdings stock split history records, China Pharma Holdings has had 2 splits. | |
|
China Pharma Holdings (CPHI) has 2 splits in our China Pharma Holdings stock split history database. The first split for CPHI took place on March 06, 2023. This was a 1 for 10 reverse split, meaning for each 10 shares of CPHI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. CPHI's second split took place on March 06, 2024. This was a 1 for 5 reverse split, meaning for each 5 shares of CPHI owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 20 share position following the split.
When a company such as China Pharma Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the China Pharma Holdings stock split history from start to finish, an original position size of 1000 shares would have turned into 20 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into China Pharma Holdings shares, starting with a $10,000 purchase of CPHI, presented on a split-history-adjusted basis factoring in the complete China Pharma Holdings stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$23.00 |
|
End price/share: |
$0.32 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.61% |
|
Average Annual Total Return: |
-34.79% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$139.20 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
03/06/2023 | 1 for 10 | 03/06/2024 | 1 for 5 |
|
|